Percutaneous edge-to-edge repair in congenital heart disease: Preliminary results of a promising new technique
2022

Percutaneous Edge-to-Edge Repair in Congenital Heart Disease

publication Evidence: low

Author Information

Author(s): Silini Alexandre, Iriart Xavier

Primary Institution: University Hospital of Bordeaux, Department of Pediatric and Adult Congenital Cardiology, France

Hypothesis

Is percutaneous edge-to-edge repair a safe and effective treatment for atrioventricular regurgitation in patients with congenital heart disease?

Conclusion

Percutaneous edge-to-edge repair appears to be a safe, effective therapeutic option for atrioventricular regurgitation in patients with congenital heart disease who are at high risk for surgical complications.

Supporting Evidence

  • Percutaneous edge-to-edge repair has shown short-term clinical and hemodynamic improvements.
  • Most cases reported significant improvement in heart failure symptoms, mainly dyspnea.
  • No intraprocedural deaths have been reported.
  • One death due to multiorgan failure was reported 5 days after the procedure.

Takeaway

Doctors are trying a new way to fix heart valves in kids and young adults with heart problems, and it seems to help them feel better without needing big surgeries.

Methodology

The authors reviewed case reports and series of patients with congenital heart disease and atrioventricular regurgitation treated with transcatheter edge-to-edge repair.

Potential Biases

The nature of case reports may lead to a biased selection of successful procedures.

Limitations

The review is based on case reports, which may introduce bias and limit the generalizability of the results.

Participant Demographics

Patients with congenital heart disease, including those with systemic right ventricle and systemic left ventricle.

Digital Object Identifier (DOI)

10.1016/j.ijcchd.2022.100370

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication